BREATHALYZERS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS 2020 - 2027
Overview of the Market
The global Breathalyzers Market was valued at USD 757.8 million in 2020, and it is predicted to grow at an annual rate of 8.5 percent to USD 1,217.7 million by 2027.
The COVID-19 virus had an impact on the breathalyser market because of the restrictions put in place to prevent the spread of infection caused by the SARS-CoV-2 virus in different parts of the world. As a result, the general public's daily routine was impacted in several ways, including a ban on travel, the closure of bars and restaurants, no visits to friends or relatives' homes, and the closure of other alcohol-selling establishments, which resulted in a short-term drop in alcohol consumption Additionally, for a brief period of time, the global fall in sales of alcohol and allied beverages had an indirect impact on the Breathalyzers Market.
Because of the increased use of alcohol and the prevalence of alcohol-related crimes and abuses around the world, some governments have enacted more strict regulations requiring the testing of alcohol levels. It is a major factor in the widespread use of breathalysers, and it is likely to be a factor in the market's future growth, as many countries still lack adequate regulatory laws against alcohol abuse. According to the National Survey on Drug Use and Health's 2019 report, 85.6 percent of adults aged 18 and above in the United States admitted to drinking alcohol at some point in their lives.
Technological improvements in breath analyzers, increased availability of prohibited medicines, increased emphasis on workplace screening, and usage of breathalysers in the diagnosis of chronic and infectious diseases are all aspects that will contribute to the market's growth. For example, Hound Labs, Inc. debuted the Hound COVID-19 Breathalyzers in September 2020, one of the world's first portable breathalysers to collect SARS-CoV-2 virus in human test participants' breath. The HOUND COVID-19 Breathalyzers were initially successfully utilised with hospitalised patients by Hound Labs.
The COVID-19 virus had an impact on the breathalyser market because of the restrictions put in place to prevent the spread of infection caused by the SARS-CoV-2 virus in different parts of the world. As a result, the general public's daily routine was impacted in several ways, including a ban on travel, the closure of bars and restaurants, no visits to friends or relatives' homes, and the closure of other alcohol-selling establishments, which resulted in a short-term drop in alcohol consumption Additionally, for a brief period of time, the global fall in sales of alcohol and allied beverages had an indirect impact on the Breathalyzers Market.
Because of the increased use of alcohol and the prevalence of alcohol-related crimes and abuses around the world, some governments have enacted more strict regulations requiring the testing of alcohol levels. It is a major factor in the widespread use of breathalysers, and it is likely to be a factor in the market's future growth, as many countries still lack adequate regulatory laws against alcohol abuse. According to the National Survey on Drug Use and Health's 2019 report, 85.6 percent of adults aged 18 and above in the United States admitted to drinking alcohol at some point in their lives.
Technological improvements in breath analyzers, increased availability of prohibited medicines, increased emphasis on workplace screening, and usage of breathalysers in the diagnosis of chronic and infectious diseases are all aspects that will contribute to the market's growth. For example, Hound Labs, Inc. debuted the Hound COVID-19 Breathalyzers in September 2020, one of the world's first portable breathalysers to collect SARS-CoV-2 virus in human test participants' breath. The HOUND COVID-19 Breathalyzers were initially successfully utilised with hospitalised patients by Hound Labs.
Comments
Post a Comment